| Shandong Chenghui Pharmaceutical Group Co., Ltd. was founded in June 2002, the registered capital of 130 million yuan, is headquartered in the famous historical and cultural city of Jinan, Shandong Province, which is surrounded by lotus flowers and willows, and a city of mountains and half a city of lakes. It is a high-tech enterprise focusing on the research and development, production, sales and service of pharmaceutical APIs, intermediates and fine chemicals, and is committed to the research and development and application of new technologies in the fields of APIs, CDMOs, veterinary drugs and agrochemicals, etc. The Group now has one R&D center, which is located in Jinan, Shandong Province.
The group now has one R&D center-Shandong Chengchuang Blue Ocean Pharmaceutical Technology Co., Ltd, one API factory-Shandong Chenghui Shuangda Pharmaceutical Co., Ltd and two pharmaceutical intermediates production bases, with more than 1,000 employees, and more than 300 R&D team members.
The group has strong scientific research and innovation ability, perfect industrialization base support and internationalized quality management system, which can meet the GMP requirements of FDA, EU, China, Korea, Japan and other countries. The products developed and manufactured by the company cover local anesthetics, antiviral drugs, cardiovascular and cerebrovascular drugs, antitumor drugs, digestive drugs, hypoglycemic drugs, veterinary drugs and other product categories. Especially in the “perioperative and antiviral” API research and production, is in a leading position, has formed a competitive product structure, products are exported to more than 70 countries and regions around the world.
With the core values of “Integrity First, Openness and Cooperation, Innovation and Leadership”, and the business philosophy of “Pursuit of Quality, Selection of Talents, Care for Employees and Green Development”, the Group continues to increase investment in research and development, adhere to the market demand-oriented, and continuously enrich the product categories, and continuously launch products with high technological content. We will continue to increase investment in research and development, adhere to the market demand-oriented, enrich product categories, continue to launch synthetic drugs with high technological content, continue to expand the international market and actively fulfill our social responsibilities, and strive to provide the world with high-quality health products, achieve the goal of sustainable development, and make greater contributions to the cause of human health!
|
CN
China Suppliers > CHENGHUI PHARMACEUTICAL GROUP LTD
Search Product